151 related articles for article (PubMed ID: 6166865)
1. Human Ia molecules carrying DC1 determinants differ in both alpha- and beta-subunits from Ia molecules carrying DR determinants.
Corte G; Calabi F; Damiani G; Bargellesi A; Tosi R; Sorrentino R
Nature; 1981 Jul; 292(5821):357-60. PubMed ID: 6166865
[No Abstract] [Full Text] [Related]
2. Distribution of antigenic determinants recognized by three monoclonal antibodies (Q2/70, Q5/6 and Q5/13) on human Ia-like alloantigens and on their subunits.
Quaranta V; Tanigaki N; Ferrone S
Immunogenetics; 1981; 12(1-2):175-82. PubMed ID: 6162791
[TBL] [Abstract][Full Text] [Related]
3. The importance of cross-reactions between species: mouse allo-anti-Ia monoclonal antibodies as a powerful tool to define human Ia subsets.
Accolla RS; Birnbaum D; Pierres M
Hum Immunol; 1983 Sep; 8(1):75-82. PubMed ID: 6195136
[TBL] [Abstract][Full Text] [Related]
4. The role of MHC class II antigenic determinants in the function of human antigen binding T8+ cells, monocytes and helper and suppressor factors.
Lehner T; Jones T
Clin Exp Immunol; 1984 Jun; 56(3):683-93. PubMed ID: 6204796
[TBL] [Abstract][Full Text] [Related]
5. Structural heterogeneity of the human Ia molecular pool as detected by cross-reacting mouse monoclonal antibodies.
Accolla RS; Pierres M
J Immunol; 1983 Jan; 130(1):283-8. PubMed ID: 6183351
[TBL] [Abstract][Full Text] [Related]
6. Human Ia molecules carrying MT1 determinants: purification with a monoclonal antibody.
Falk JA; Lewis WH; Letarte M
Hum Immunol; 1985 Aug; 13(4):265-80. PubMed ID: 2411699
[TBL] [Abstract][Full Text] [Related]
7. The role of three distinct Ia-like antigen molecules in human T cell proliferative responses: effect of monoclonal anti-Ia-like antibodies.
Koide Y; Awashima F; Yoshida TO; Takenouchi T; Wakisaka A; Moriuchi J; Aizawa M
J Immunol; 1982 Sep; 129(3):1061-9. PubMed ID: 6179989
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to polymorphic epitopes on Ia antigens: three independent groups of determinants expressed on DRw6 homozygous cells.
Johnson JP; Wank R
Eur J Immunol; 1984 Aug; 14(8):739-44. PubMed ID: 6205884
[TBL] [Abstract][Full Text] [Related]
9. Human Ia molecules carrying DC1 or BR4X7 determinants are not homologous to murine I-E molecules.
Tosi R; Tanigaki N; Sorrentino R; van Mourik P; Ivanyi P
Immunogenetics; 1982; 16(3):187-99. PubMed ID: 6815072
[TBL] [Abstract][Full Text] [Related]
10. Expression and synthesis of murine immune response-associated (Ia) antigens by brain cells.
Ting JP; Shigekawa BL; Linthicum DS; Weiner LP; Frelinger JA
Proc Natl Acad Sci U S A; 1981 May; 78(5):3170-4. PubMed ID: 6166944
[TBL] [Abstract][Full Text] [Related]
11. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
Karr RW; Lipman LK; Alber C; Koning F; Goeken NE
J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807
[TBL] [Abstract][Full Text] [Related]
12. Detection of Ia epitopes by monoclonal antibody blotting.
Deane DL; Cohen BB; Moxley M; Steel CM
Immunol Lett; 1983 Feb; 6(2):93-6. PubMed ID: 6189782
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the structural heterogeneity and polymorphism of human Ia antigens. Four distinct subsets of molecules are coexpressed in the Ia pool of both DR1,1 homozygous and DR3,W6 heterozygous B cell lines.
Accolla RS
J Exp Med; 1984 Feb; 159(2):378-93. PubMed ID: 6420499
[TBL] [Abstract][Full Text] [Related]
14. Purification of immunologically functional subsets of human Ia-like antigens on a monoclonal antibody (Q5/13) immunoadsorbent.
Quaranta V; Walker LE; Pellegrino MA; Ferrone S
J Immunol; 1980 Oct; 125(4):1421-5. PubMed ID: 6157732
[TBL] [Abstract][Full Text] [Related]
15. Differential expression and serologically distinct subpopulations of human Ia antigens detected with monoclonal antibodies to Ia alpha and beta chains.
Guy K; Van Heyningen V; Cohen BB; Deane DL; Steel CM
Eur J Immunol; 1982 Nov; 12(11):942-8. PubMed ID: 6185348
[TBL] [Abstract][Full Text] [Related]
16. Microfingerprinting analysis of human Ia molecules favours a three loci model.
Sorrentino R; Corte G; Calabi F; Tanigaki N; Tosi R
Mol Immunol; 1983 Mar; 20(3):333-43. PubMed ID: 6191204
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR epitope region definition by use of monoclonal antibody probes.
Grumet FC; Charron DJ; Fendly BM; Levy R; Ness DB
J Immunol; 1980 Dec; 125(6):2785-9. PubMed ID: 6159421
[TBL] [Abstract][Full Text] [Related]
18. Further characterization of two "DR supertypic" specificities. Additional evidence that they reside on molecules different from those carrying HLA-DR locus specificities.
Tanigaki N; Tosi R; Centis D; Ferrara GB; Pressman D
Hum Immunol; 1981 Oct; 3(2):93-108. PubMed ID: 6173362
[TBL] [Abstract][Full Text] [Related]
19. Biochemical variation of human Ia like antigens detected with monoclonal antibodies.
Cohen BB; Deane DL; Van Heyningen V; Guy K; Hutchins D; Moxley M; Steel CM
Clin Exp Immunol; 1983 Jul; 53(1):41-50. PubMed ID: 6191895
[TBL] [Abstract][Full Text] [Related]
20. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
